DDX3Y encodes a class I MHC–restricted H-Y antigen that is expressed in leukemic stem cellsKellie V. Rosinski, Edus H. Warren|Blood|2008Cited by 66
139 | ENHANCED CAR T‐CELL EXPANSION AND DURABLE COMPLETE RESPONSES WITH NKTR‐255 PLUS LISOCABTAGENE MARALEUCEL IN RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMAAlexandre V. Hirayama, Cameron J. Turtle, Ryan D. Cassaday et al.|Hematological Oncology|2025Cited by 1
High-dose anakinra to treat refractory immune effector cell-associated neurotoxicity syndrome in CAR T-cell therapy recipientsEmily C. Liang, Richard T. Maziarz, Smith Kungwankiattichai et al.|Blood|2025Cited by 0
Outcomes of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS) in Patients Receiving Frontline Anakinra and CorticosteroidsEmily C. Liang, Jordan Gauthier, Dwight C Macero et al.|Transplantation and Cellular Therapy|2026Cited by 0
Idiopathic Post-CAR-T Hypotension: Prevalence and Management with Midodrine and/or FludrocortisoneChristy Khouderchah, Mazyar Shadman, Mehdi Karami et al.|Transplantation and Cellular Therapy|2026Cited by 0